Dr. Bryan Rabatic (PGY 5)

Education

  • Undergraduate: The George Washington University, Washington, DC 
  • Graduate School: Northwestern University, Evanston, IL 
  • Medical School: Rush University Medical College, Chicago, IL 
  • Internship: Rush University Medical Center, Chicago, IL 
  • Residency (2014-2016): Medical College of Georgia, Augusta, GA 


Honors and Awards

  • Undergraduate:
    • A.D. Britt Scholar, The George Washington University, Washington, D.C.
  • Postdoctoral:
    • Center for Nanoscale Materials Distinguished Postdoctoral Fellow,


Research Interests

Head and neck cancer, breast cancer, stereotactic radiosurgery/stereotactic body radiotherapy


Publications (recent)
(as of 9/19/17)

  • Rabatic BM, Kong FM. Rebuttal: Concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable Stage III non-small cell lung cancer. Transl Lung Cancer Res 2016;5(2):198-200. PMID: 27186515.
  • Rabatic BM, Kong FM. Pros: Concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable Stage III non-small cell lung cancer. Transl Lung Cancer Res 2016;5(2):190-194. PMID: 27186513.
  • Zaenger D, Rabatic BM, Dasher B, Mourad WM. Is breast conserving therapy a safe modality for early stage male breast cancer? Clin Breast Cancer 2016;16(2):101-104. PMID: 26718092
  • Amoush A, Dalton A, Rabatic BM, Huang K, Al-Basheer A. Volumetric modulated arc therapy for spine SBRT patients to reduce treatment time and intrafractional motion. Int J Cancer Ther Oncol 2015;3(2):03026. doi.org/10.14319/ijcto.0302.6.   
  • Kurepa J, Paunesku T, Vogt S, Arora H, Rabatic BM, et al. Uptake and distribution of ultrasmall Anatase TiO2 Alizarin red S nanoconjugates in Arabidopsis thaliana. Nano Letters 2010;10(7):2296-302. PMID: 20218662.


Book Chapters

  • Rabatic BM. Experimental therapies in breast cancer. In: Kauczor, H (ed.), Breast Cancer for the Radiation Oncologist, pp. 81-90. 2015; Berlin & Heidelberg: Springer-Verlag.
  • Arora H, Doty C, Yuan Y, Boyle J, Petras K, Rabatic BM, et al. Titanium dioxide nanocomposites. In Kumar CS (Ed.), Nanomaterials for the Life Sciences, Volume 8: Nanocomposites, pp.1-42. 2010; Weinheim: Wiley-VCH Verlag GmbH & Co.


Meeting Abstracts/Presentations (recent)

  • Rabatic BM, DeRossi S, Mourad WF, et al. Dynamic changes of major salivary glands during head and neck IMRT. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Rabatic BM, DeRossi S, Mourad WF, et al. Quantitative dose changes due to anatomic and volumetric changes of the parotid glands during concurrent head and neck therapy. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Nettles M, DeRossi S, Mourad, WF, Rabatic BM. Head and neck lymphedema: Reducing a growing problem. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Zaenger D, Rabatic BM, Mourad WF, et al. Is individualized dose intensification appropriate for inflammatory breast cancer? American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Zaenger D, Rabatic BM, Mourad WF, et al. Impact of health disparities on outcomes: Do black women with inflammatory breast cancer require individualized treatment intensification? American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Zaenger D, Rabatic BM, Mourad WF, et al. Modern demographics, oncologic outcomes, and prognostic factors in women with inflammatory breast cancer. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Madden N, Rabatic BM, Mourad WF, et al. Development of secondary malignant neoplasms in pediatric patients diagnosed with glioblastoma or anaplastic astrocytoma. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Madden N, Rabatic BM, Mourad WF, et al. Trends in utilization of radiation in the treatment of pediatric Hodgkin's lymphoma. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Marascio J, Rabatic BM, Mourad WF, et al. Evaluating the impact of sentinel node biopsy in Merkel cell carcinoma. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Marascio J, Rabatic BM, Mourad WF, et al. Oncologic outcome of bi-modality approach for cutaneous adnexal carcinoma. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Marchan E, Rabatic BM, Mourad WF, et al. The role of internationally standardized radiosurgery treatment parameters in predicting long term trigeminal neuralgia outcomes. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Amoush A, Rabatic BM, Mourad WF, et al. Dosimetric study of the effect of the 6D Calypso-compatible couch top and rails for spine stereotactic body radiation therapy. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Shaaban S, Rabatic BM, Mourad WF, et al. Risk of second primary malignancy in head and neck cancer patients: A population-based study. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Poster presentation.)
  • Madden N, Rabatic BM, Mourad WF, et al. Factors associated with secondary malignancy in pediatric Hodgkin’s lymphoma. American Society for Clinical Oncology Annual Meeting, Chicago, IL, June 3-7, 2016.  (Poster presentation.)
  • Rabatic BM, DeRossi S, Mourad WF, et al. Chemotherapy-related qualitative, quantitative, anatomic and volumetric changes of the major salivary glands during concurrent head and neck therapy. American Society for Clinical Oncology Annual Meeting, Chicago, IL, June 3-7, 2016. (ePoster.)
  • Marascio J, Rabatic BM, Mourad WF, et al. Renal cell carcinoma: The effect of targeted therapies on clear cell and non-clear cell histologies. American Society for Clinical Oncology Annual Meeting. Chicago, IL, June 3-7, 2016. (ePoster.)
  • Zaenger D, Rabatic BM, Mourad WF, et al. Mastectomy versus breast conservation for early stage male breast cancer? American Radium Society Annual Meeting, Philadelphia, PA, April 16-19, 2016. (Poster presentation.)
  • Rabatic BM, Ferguson C, Ghamande SA, et al. Real-time robot-assisted interstitial brachytherapy for locally advanced cervical cancer: Feasibility and toxicity. American Society for Radiation Oncology Annual Meeting, San Antonio, TX, October 18-21, 2015. (Poster presentation.)
  • Rabatic BM, Chen J, Kong FM, et al. Principle component analysis of plasma cytokine changes during SBRT in patients with NSCLC. American Society for Radiation Oncology Annual Meeting, San Antonio, TX, October 18-21, 2015. (Poster presentation.)
  • Rabatic BM, Mourad WF, Hu KS, et al. The impact of HPV, HIV, and smoking on oncologic and functional outcomes in patients with head and neck cancer. American Radium Society Annual Meeting, Koloa, HI, May 2-5, 2015. (Oral presentation.)
  • Rabatic BM, Zaenger D, Mourad WF. Oncologic and functional outcomes of salivary gland tumors (SGT) with pathologically proven perineural invasion (PNI). American Radium Society Annual Meeting, Koloa, HI, May 2-5, 2015. (Poster presentation.)
  • Zaenger D, Rabatic BM, Kaminski J, Mourad WF. Long-term functional oncologic outcomes of Esthesioneuroblastoma. American Radium Society Annual Meeting, Koloa, HI, May 2-5, 2015. (Poster presentation.)
  • Zaenger D, Woodall MN, Rabatic BM, et al. Clinical outcomes of Gamma Knife Stereotactic Radiosurgery for painful trigeminal neuropathy. American Radium Society Annual Meeting, Koloa, HI, May 2-5, 2015. (Poster presentation.)
  • Zaenger D, Schulz R, Rabatic BM, et al. From benign CNS SRS therapy to SRS treatments for facetogenic pain: Extrapolating safety. American Association of Neurological Surgeons Annual Meeting, Washington, DC, May 2-5, 2015. (Poster presentation.)